Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
51.06
-1.23 (-2.35%)
At close: Feb 18, 2026, 4:00 PM EST
51.08
+0.02 (0.04%)
After-hours: Feb 18, 2026, 4:20 PM EST

Phibro Animal Health Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
1,4641,2961,018977.89942.26833.35
Revenue Growth (YoY)
32.39%27.37%4.07%3.78%13.07%4.12%
Cost of Revenue
991.31890.59704.07679.65656.55561.97
Gross Profit
473.02405.62313.61298.24285.72271.38
Selling, General & Admin
291.13269.68247.09223.35183.53193.82
Research & Development
----20.83-
Amortization of Goodwill & Intangibles
2.382.382.993.052.982.69
Operating Expenses
293.51272.06250.07226.39207.34196.51
Operating Income
179.51133.5663.5471.8578.3874.87
Interest Expense
-43.71-35.26-23.01-18.68-12.69-12.7
Interest & Investment Income
1.932.624.473.360.820.84
Currency Exchange Gain (Loss)
-0.81-7.87-23.86-2.465.224.48
EBT Excluding Unusual Items
136.9293.0521.1454.0771.7267.49
Merger & Restructuring Charges
-16.1-25.98-6.93--0.6-
Gain (Loss) on Sale of Investments
----1.2-
Legal Settlements
---4.2---
Other Unusual Items
--1.96----1.02
Pretax Income
126.2367.9910.9254.0772.3366.47
Income Tax Expense
34.1419.738.521.4723.1512.08
Net Income
92.0948.262.4232.6149.1854.39
Net Income to Common
92.0948.262.4232.6149.1854.39
Net Income Growth
376.73%1897.68%-92.59%-33.69%-9.58%62.09%
Shares Outstanding (Basic)
414141414140
Shares Outstanding (Diluted)
414141414141
Shares Change (YoY)
0.53%0.38%0.05%---
EPS (Basic)
2.271.190.060.811.211.34
EPS (Diluted)
2.261.190.060.811.211.34
EPS Growth
373.98%1895.04%-92.59%-33.47%-9.70%61.57%
Free Cash Flow
47.2941.8346.36-38.48-5.418.99
Free Cash Flow Per Share
1.161.031.14-0.95-0.130.47
Dividend Per Share
0.4800.4800.4800.4800.4800.480
Gross Margin
32.30%31.29%30.82%30.50%30.32%32.56%
Operating Margin
12.26%10.30%6.24%7.35%8.32%8.98%
Profit Margin
6.29%3.72%0.24%3.33%5.22%6.53%
Free Cash Flow Margin
3.23%3.23%4.55%-3.94%-0.57%2.28%
EBITDA
228.84177.7598.28104.4110.04105.5
EBITDA Margin
15.63%13.71%9.66%10.68%11.68%12.66%
D&A For EBITDA
49.3344.1834.7432.5631.6630.63
EBIT
179.51133.5663.5471.8578.3874.87
EBIT Margin
12.26%10.30%6.24%7.35%8.32%8.98%
Effective Tax Rate
27.04%29.02%77.87%39.70%32.01%18.18%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q